Chemotherapy for Mesothelioma

Written by

Antoine DuBois
Writter & Researcher

Reviewed by

Robert Brown
Editor

Get Your Free Guide

We’ll send the right guide based on what you need—treatment basics, support, research updates, or practical checklists.

Chemotherapy and Side Effects: A Practical Guide for Mesothelioma Patients

Chemotherapy remains a core tool for treating asbestos, mesothelioma. Many people face mesothelioma after years of asbestos exposure, often at work or in the military. This guide explains what chemotherapy does, how it is given, and what side effects to expect. It also shares simple tips for side effect management. Care plans differ by cancer stage, type, and personal goals. That includes pleural mesothelioma in the chest and peritoneal mesothelioma in the abdomen. The goals of therapy are clear: control cancer, ease symptoms, and help people live longer with better comfort. Below you will find sections on treatment approach, common regimens, side effects, and day-to-day coping.

If you need more information about making a claim, you can contact Danziger & DeLlano LLP at www.dandell.com.

How does chemotherapy treat mesothelioma after asbestos exposure?

Chemotherapy uses drugs that attack fast-growing cancer cells. For mesothelioma, chemo can reach cancer cells that surgery or radiation might miss. Doctors use it when mesothelioma has spread or when they aim to shrink tumors, ease symptoms, or prepare for surgery.

Most people receive systemic chemotherapy. This means drugs flow through a vein and travel throughout the body. Treatment happens in cycles. A cycle has an infusion day, then a rest period so the body can recover. You may sit in an infusion chair for a few hours on treatment days. Many patients receive treatment through a port, a small device placed under the skin. A port makes infusions smoother and protects veins.

Peritoneal mesothelioma may be treated with surgery plus heated chemotherapy in the abdomen, often called HIPEC. This approach delivers drugs directly into the belly during the same operation. Systemic chemo is still used for many patients, and doctors may combine both approaches based on goals and timing. For an overview of how centers structure chemotherapy and manage side effects, see NYU Langone’s guide to chemotherapy for malignant mesothelioma.

Doctors decide on chemotherapy after reviewing several factors. These include the cancer stage, tumor location, and whether disease is pleural or peritoneal. They also look at other health issues, lungs and kidney function, and what matters most to you. Plans are tailored and may change over time.

For context on standard therapies across surgery, radiation, and drug treatment, review this summary of Mesothelioma treatment options.

Treatment goals for mesothelioma chemotherapy

  • Shrink or slow tumors to control growth.
  • Lessen symptoms, such as chest pain, cough, or shortness of breath.
  • Improve comfort and daily function.

Chemo may be given:

  • Before surgery, to shrink tumors and make surgery easier.
  • After surgery, to kill any cells left behind.
  • When surgery is not possible, to control disease and ease symptoms.

How chemotherapy works in the body

Chemotherapy targets cells that divide quickly. Cancer cells tend to divide faster than most healthy cells, so chemo can slow or stop them. Systemic IV chemo treats the whole body. HIPEC provides heated chemo inside the abdomen during surgery for peritoneal mesothelioma. The heat helps the drugs spread in the abdomen and may boost their effect.

What to expect during a chemo cycle

  • Pre-chemo labs to check blood counts and organ function.
  • Premedications to reduce nausea or allergic reactions.
  • Time in the infusion chair, often a few hours.
  • A rest period of days to weeks.

A cycle repeats on a schedule set by your team. Many people receive a port to make IV access easier, reduce needle sticks, and protect veins.

Who may benefit and how teams decide

Teams consider how far the cancer has spread, overall strength and activity level, kidney function, and other health problems. Preferences matter too. If cisplatin is hard on the kidneys, doctors may choose a different drug. The link to asbestos and the type of mesothelioma, pleural or peritoneal, guides strategy. Plans are personalized to match risks and goals.

Which chemotherapy regimens are used for mesothelioma?

Several combinations are well established in pleural and peritoneal disease. The most common starting approach uses two drugs. The exact plan depends on your health, test results, and center experience. Some regimens include supportive vitamins to reduce side effects. Your team will explain why a drug was chosen and how long therapy should last.

For a detailed overview of chemotherapy types and typical side effects, you can review The Mesothelioma Center’s summary on chemotherapy for mesothelioma.

First-line standard for pleural mesothelioma

A common first-line choice is pemetrexed plus a platinum drug. Cisplatin is often used, with carboplatin as an alternative. Pemetrexed is paired with folic acid and vitamin B12 to reduce side effects. Many teams also give a short steroid during treatment days. These steps can lower the risk of severe rash, mouth sores, and fatigue.

Add-ons and regimen variants

Some patients may receive bevacizumab with chemotherapy if they qualify. This decision depends on blood pressure, bleeding risks, and other factors. Carboplatin can replace cisplatin when kidney function is reduced or other concerns arise. Your team will match the drug to your health profile.

Peritoneal mesothelioma and HIPEC

Some centers offer cytoreductive surgery, which removes visible tumors in the abdomen, followed by heated chemo in the abdomen during the same operation. This is known as HIPEC. Not everyone is a candidate. When surgery or HIPEC are not options, systemic chemo may be used to control disease and support quality of life.

Options after first-line treatment

If the first regimen stops working, doctors may consider other drugs. Common second-line chemotherapy options include gemcitabine or vinorelbine. Your team may also discuss clinical trials that could offer access to new treatments. Learn about how studies are structured and who may qualify at Mesothelioma clinical trials. For a pharmacology-focused view of current regimens and second-line choices, see Cancer Therapy Advisor’s summary of mesothelioma pharmacologic treatment.

What side effects should you expect from mesothelioma chemotherapy?

Side effects vary by drug, dose, and your own health. Many side effects are temporary and improve during the rest period. Some effects can be urgent and need quick care. Your team will explain which to expect and how to respond. Simple tracking can help you and your clinicians make timely changes.

For day-to-day management ideas, see this practical guide on managing mesothelioma chemotherapy side effects.

Common short-term effects

Nausea, vomiting, and fatigue are common. Hair loss, mouth sores, and taste changes can occur. Some people lose appetite or have diarrhea or constipation. These effects often peak a few days after the infusion, then improve before the next cycle. Premedications and home remedies can help.

Low blood counts and infection risk

Chemotherapy can lower white cells, red cells, and platelets. Low white cells raise infection risk. Fever at 100.4°F (38°C) or higher is an urgent warning. Call your team right away if this occurs. Low red cells can cause fatigue and shortness of breath. Low platelets can cause easy bruising or bleeding. Some people receive growth factor shots to support white cell recovery.

Drug-specific concerns to watch

  • Cisplatin can affect the kidneys, hearing, and nerves. Report reduced urine, ringing in the ears, or numbness in hands and feet.
  • Carboplatin often lowers platelets. Report unusual bruising or nosebleeds.
  • Pemetrexed can cause rash. Vitamins and steroids reduce this risk, but report any new or spreading rash.

How side effects change over time

Some side effects build with each cycle. Fatigue can deepen, and numbness may spread. Keep a simple symptom log with dates and severity. Share it at each visit. Early reporting helps your team adjust doses or add support.

Quick reference: common timing and when to act

| Side effect | Typical timing after infusion | When to call right away | | ------------------ | ----------------------------- | ------------------------------------------------- | | Nausea or vomiting | 1 to 3 days | Vomiting that prevents fluids for 12 hours | | Fatigue | 2 to 5 days, can linger | Sudden severe weakness or fainting | | Fever | Any time, often days 7 to 14 | 100.4°F (38°C) or higher | | Diarrhea | 2 to 5 days | 6 or more stools per day, blood, or severe cramps | | Mouth sores | 3 to 7 days | Sores that stop eating or drinking | | Bruising/bleeding | 7 to 14 days | Nosebleeds that do not stop in 20 minutes | | Reduced urination | Any time | No urine for 12 hours or very dark urine |

How can you manage chemotherapy side effects and stay safe?

Small daily steps can make a big difference. Many side effects can be reduced with planning, simple routines, and quick outreach to your team. Your clinic may also have local guides with recipes, activity tips, and phone numbers for after-hours questions.

For a broader view of how centers prevent and treat common symptoms, see NYU Langone’s section on managing chemotherapy side effects.

Nausea, appetite, and hydration

  • Take anti-nausea medications on schedule, not just when you feel sick.
  • Choose small, frequent meals. Bland foods like crackers, toast, rice, and bananas help.
  • Sip fluids often. Aim for pale yellow urine.
  • Keep favorite high-calorie snacks ready, such as yogurt, nut butter, or smoothies.
  • Suck on ginger candies or mints if taste changes bother you.

Protecting blood counts and avoiding infection

  • Wash hands often and use alcohol-based sanitizer when out.
  • Brush gently twice daily and rinse with a baking soda and salt mix.
  • Prepare food carefully. Wash produce, cook meats well, and avoid raw eggs or sushi during low counts.
  • Avoid sick contacts. Crowds can be risky when white cells are low.
  • Ask your oncology team about vaccine timing before getting any shots.

Kidney, hearing, and nerve care

  • If you receive cisplatin, drink fluids as advised and attend all lab checks.
  • Report reduced urine, swelling in the legs, or sudden weight gain.
  • Call if you notice ringing in your ears or hearing changes.
  • If numbness starts, protect hands and feet. Wear shoes at home, use gloves in the kitchen, and take care with sharp tools.

When to call the care team or seek urgent help

Contact your team or go to urgent care for:

  • Fever 100.4°F or higher, or shaking chills.
  • Shortness of breath, chest pain, or confusion.
  • Inability to keep fluids down for 12 hours.
  • Blood in stool or urine, or black tarry stools.
  • No urination for 12 hours.
  • Severe diarrhea, signs of dehydration, or dizziness that does not improve.

For a broader treatment overview that connects chemotherapy with surgery and radiation planning, you can review Standard therapies for malignant mesothelioma.

If you or a loved one has questions about asbestos exposure and compensation, you can reach Danziger & DeLlano LLP at www.dandell.com.

Conclusion

Chemotherapy for asbestos, mesothelioma aims to control tumors, ease symptoms, and extend life. The most common first-line plan pairs pemetrexed with a platinum drug, with other options used as needed. Side effects are common but often manageable with simple routines and timely support. Write down your questions for the next visit. Ask about goals of care, the expected benefit of each drug, and options if side effects become hard. If you need information about claims linked to asbestos exposure, contact Danziger & DeLlano LLP at www.dandell.com. Your care team can help tailor treatment so you stay as strong and comfortable as possible.

Talk to a Patient Advocate

Share a few details and we’ll help you plan next steps and connect resources.

Authors & Editors

Antoine DuBois
Writter & Researcher
Robert Brown
Editor

Last updated: 2025-11-20